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Abstract A 58-year-old woman presented with non-
radicular pain in the upper thorax. Due to the prolonged
duration of symptoms, a bone scintigraphy was made,
which showed pathological enhancement in the upper
thoracic spine. An MRI demonstrated lesions of the
third and fourth thoracic vertebrae. A biopsy showed a
metastasis of poorly diﬀerentiated carcinoma. A whole-
body 18-F-FDG PET scan failed to identify a primary
tumour. The patient was given radiotherapy, chemo-
therapy and analgesic treatment. She died within
3 years. In the late stage, the tumour marker CA 19-9
was positive; however, an MRI of the abdomen failed to
identify a pancreatic tumour. Metastasis from an un-
known primary site can present as cervical spinal disease
very similar to degenerative disease.
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Introduction
Cervical spinal pain is a common symptom in patients
with degenerative changes of the cervical spine or
myofascial pain syndrome. An X-ray is not necessarily
the ﬁrst examination if no red ﬂag [1] is present. Usually,
the patients in our department are treated with NSAIDs,
myorelaxants and/or physical therapy and followed up
carefully. Laboratory tests and X-rays are performed
only if the patient’s condition does not improve within
2–4 weeks.
Case report
A 58-year-old woman was admitted to our university
hospital in September 2000 with a 10-month history of
back pain in the upper thorax that did not respond well
to physiotherapy or systemic analgesics. Physical
examination revealed an afebrile, obese (BMI 35.7 kg/
m2) patient with normal ﬁndings except a slight pain on
percussion of the third and fourth thoracic vertebrae.
Laboratory tests (ESR, CRP, electrolytes, liver enzymes
and creatinine) were normal. Lactate dehydrogenase
(LDH) was not determined. The whole-body techne-
tium-99 scintigraphy showed a massive focal uptake in
the upper part of the thoracic vertebral column. In
addition, an MRI of the cervical and thoracic spine
disclosed increased signal intensity of the third and
fourth thoracic vertebrae with an intense uptake of
contrast media in the contiguous soft tissue (Fig. 1a). A
CT scan of the neck, chest and abdomen and an MRI of
the abdomen showed a lobular cystic lesion in the right
liver lobe but no signs for primary tumour. An 18F-
FDG PET conﬁrmed the high FDG uptake of the third
and fourth thoracic vertebrae (Fig. 1d). The lesion of the
right liver lobe showed only a low uptake and was
thought to be a cyst.
Since a CT-guided bone biopsy of the third thoracic
vertebra showed only necrotic bone tissue, open biopsy
was performed. It revealed metastasis from poorly dif-
ferentiated carcinoma of unknown origin. The neoplas-
tic cells stained positive for cytokeratin and S100 but
were negative for the oestrogen and progesterone
receptor. Other tumour markers (AFP, CEA, CA125,
CA15-3, CA19-9) were negative at this time.
This revised version was published online in March 2005 with
corrections to Figure 1.
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The patient received local percutaneous radiotherapy
with 20·2 Gy (totally 40 Gy) from November 2000 to
December 2000 with a curative intent [2]. Her symptoms
diminished under therapy. Seven months later, she suf-
fered from back pain again at the same thoracic level. A
PET scan revealed a high FDG uptake in the third
thoracic vertebra and additionally in the os sacrum and
a left supraclavicular lymph node. The cystic lesion in
the right liver lobe was larger than at the earlier exam-
ination with a focal FDG uptake at the margins. It was
now assumed to be a cystic metastasis. In view of the
clearly visible tumour progression, we decided to start
chemotherapy with paclitaxel (175 mg/m2) and car-
boplatin (AUC 6) as an intravenous infusion every 3
weeks. The PET scan after three courses showed no
further FDG uptake, and thus a complete remission was
postulated. A total of six courses were given.
In May 2002, 2 months after the end of the chemo-
therapy, the patient again complained of considerable
pain in the upper back. The patient decided to try a
homeopathic procedure, to which she did not respond.
Three months later, the back pain worsened and resulted
in pain-related immobility. She developed paraplegia
with weakness of both legs. An MRI yielded compres-
sion of the spinal cord at the level of the third and fourth
thoracic vertebrae. The patient was transferred to the
Department of Surgery where laminectomy, tumour
debulking and dorsal stabilisation were performed.
Shortly thereafter, a deep vein thrombosis in the right
calf was diagnosed, and therapy with low-molecular-
weight heparin was started. The backache was the main
problem and was ﬁnally controlled with hydromor-
phone. In October 2002, the patient was referred to a
rehabilitation clinic. There, a second deep vein throm-
bosis of the left leg was diagnosed, and an oral anti-
coagulation with phenprocoumon was started.
In the course of the next 3 months, the patient’s
mobility deteriorated continuously. At the beginning of
January 2003, she experienced sharp pain and cramps in
the upper abdomen. On examination, her liver was
markedly enlarged. The laboratory test revealed elevated
values of alanine aminotransferase (ALT), alkaline
phosphatase, bilirubin and LDH, and for the ﬁrst time
elevated CA 19-9. Four weeks later, she was admitted to
the emergency ward of a local hospital because of a
sudden exacerbation of pain in the upper abdomen. The
INR value was >7. An ultrasonography showed a large,
partially cystic, partially solid lesion in the liver. An
acute haemorrhage from the liver lesion was postulated.
The bleeding was thought to be caused by tumour pro-
gression and anti-coagulation. Except for pain medica-
tion, the patient desired no further therapy. She died 1
day after admission. On request of her family, no
autopsy was performed.
Discussion
Metastatic cancer is among the most frequent causes of
skeletal pain in adults [3]. Patients without a known
primary carcinoma present a diagnostic dilemma. Pros-
tate, breast and lung neoplasms account for approxi-
mately 60% of the metastasis [4]. Bone scintigraphy is
more sensitive than radiography and provides a survey
of the entire skeleton. However, increased uptake seen
on bone scintigraphy is not speciﬁc, and some neoplasms
are poorly detected by scintigraphy [3]. In 30% of pa-
tients, the primary carcinomas cannot be identiﬁed when
bone metastases are ﬁrst diagnosed [5]. MRI and PET
may be helpful in detecting and deﬁning the extent and
precise location of bone marrow lesions and the exten-
sion of soft tissue neoplasms [6].
Pain could be an important indicator of bone metas-
tasis. Although most patients with bone metastases re-
port bone pain, a signiﬁcant fraction (21% of breast and
22% of prostate cancer patients) is asymptomatic [7].
Fig. 1 Osteoplastic lesions of
the third and fourth thoracic
vertebrae on MRI
(a), conventional X-ray (b) and
CT scan (c). Pathological
ﬁndings are indicated with
asterisks. 18-F-FDG PET scans
(d) revealed high FDG uptake
in the third thoracic vertebra
(red spots)
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However, pain is not a reliable indicator of the presence
of metastatic bone disease. Metastatic bone disease
should be taken into consideration in patients with spinal
pain who do not respond well to conventional treatment
with NSAIDs, myorelaxants and/or physical therapy.
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